Charlotte's Web Holdings (CWBHF) Common Equity (2020 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Common Equity of -$15.0 million for Q1 2026, down 171.41% year-over-year from $21.1 million in Q1 2025, and down 637.67% quarter-over-quarter from -$2.0 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Common Equity (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Common Equity for 7 consecutive years, with -$15.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 171.41% year-over-year to -$15.0 million; the TTM figure through Mar 2026 stood at -$15.0 million (down 171.41% YoY), while the FY2025 annual figure was -$2.0 million, down 107.53% from the prior year.
- Common Equity declined to -$15.0 million in Q1 2026 per CWBHF's latest filing, from -$2.0 million in the prior quarter.
- Across five years, Common Equity topped out at $123.2 million in Q1 2022 and bottomed at -$15.0 million in Q1 2026.
- Historically, Common Equity has averaged $50.9 million across 5 years, with a median of $46.7 million in 2024.
- Annual changes were most pronounced in 2023 — Common Equity declined 28.32% — and 2026, when it tumbled 171.41%.
- Charlotte's Web Holdings' Common Equity stood at $77.5 million in 2022, then slipped by 28.32% to $55.6 million in 2023, then sank by 51.25% to $27.1 million in 2024, then slumped by 107.53% to -$2.0 million in 2025, then tumbled by 637.67% to -$15.0 million in 2026.
- Business Quant data shows CWBHF's Common Equity at -$15.0 million in Q1 2026, -$2.0 million in Q4 2025, and $9.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Charlotte's Web Holdings | 63.58 Mn | 49.59 Mn | 5.16 Mn | 56.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.06 Mn |
| Mar 31, 2026 | -15.04 Mn |
| Dec 31, 2025 | -2.04 Mn |
| Sep 30, 2025 | 9.25 Mn |
| Jun 30, 2025 | 14.93 Mn |
| Mar 31, 2025 | 21.06 Mn |
| Dec 31, 2024 | 27.09 Mn |
| Sep 30, 2024 | 30.24 Mn |
| Jun 30, 2024 | 35.83 Mn |
| Mar 31, 2024 | 46.67 Mn |
| Dec 31, 2023 | 55.56 Mn |
| Sep 30, 2023 | 63.74 Mn |
| Jun 30, 2023 | 78.36 Mn |
| Mar 31, 2023 | 74.90 Mn |
| Dec 31, 2022 | 77.51 Mn |
| Sep 30, 2022 | 108.86 Mn |
| Jun 30, 2022 | 115.91 Mn |
| Mar 31, 2022 | 123.15 Mn |
| Dec 31, 2021 | 130.45 Mn |
| Sep 30, 2021 | 241.98 Mn |